SBC Medical Group Holdings Incorporated
SBC
$2.99
$0.031.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -9.02% | -10.93% | -18.33% | -18.35% | -13.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.02% | -10.93% | -18.33% | -18.35% | -13.65% |
| Cost of Revenue | 32.50% | 0.85% | 29.41% | -2.44% | -37.24% |
| Gross Profit | -19.58% | -14.60% | -29.20% | -23.87% | -4.52% |
| SG&A Expenses | -4.60% | 11.89% | -51.17% | 22.79% | -8.33% |
| Depreciation & Amortization | -32.70% | 14.05% | 3.72% | 82.37% | -52.37% |
| Other Operating Expenses | -66.44% | -84.32% | -53.30% | 296.38% | 145.25% |
| Total Operating Expenses | 9.57% | 8.42% | -30.01% | 11.60% | -23.79% |
| Operating Income | -26.78% | -35.03% | 14.79% | -46.67% | -1.06% |
| Income Before Tax | -40.05% | 206.42% | 41.19% | -50.01% | 15.62% |
| Income Tax Expenses | -24.42% | 977.43% | -44.77% | 30.15% | 17.84% |
| Earnings from Continuing Operations | -47.29% | 118.08% | 352.75% | -86.85% | 14.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -299.05% | -814.94% | -443.75% | 125.24% | 40.00% |
| Net Income | -47.41% | 117.16% | 352.70% | -86.70% | 14.63% |
| EBIT | -26.78% | -35.03% | 14.79% | -46.67% | -1.06% |
| EBITDA | -25.94% | -34.70% | 11.95% | -45.98% | -2.55% |
| EPS Basic | -47.07% | 117.61% | 319.13% | -87.92% | 4.57% |
| Normalized Basic EPS | -16.58% | -15.44% | 29.01% | -54.25% | -11.46% |
| EPS Diluted | -47.07% | 117.61% | 319.13% | -87.92% | 4.57% |
| Normalized Diluted EPS | -16.58% | -15.44% | 29.01% | -54.25% | -11.46% |
| Average Basic Shares Outstanding | -0.68% | -0.18% | 7.94% | 9.89% | 9.64% |
| Average Diluted Shares Outstanding | -0.68% | -0.18% | 7.94% | 9.89% | 9.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |